Skip to content

Gilead Sciences

NASDAQ: GILD · USD

Gilead Sciences cash flow and EPS—

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$12,750M
Gilead Sciences capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q28.06% · $20.874MUnavailable91.94% · $238.179MUnavailableUnavailable100% · $259.053M
FY 2009 Q35.92% · $18.125M0% · $0M94.08% · $288.247MUnavailable0.01% · $0.023M100% · $306.395M
FY 2009 Q410.03% · $26.987M0% · $0M89.95% · $242.004MUnavailable0.02% · $0.049M100% · $269.04M
FY 2010 Q16.7% · $11.666MUnavailable93.3% · $162.52MUnavailableUnavailable100% · $174.186M
FY 2010 Q20.94% · $16.051MUnavailable99.06% · $1,691.561MUnavailableUnavailable100% · $1,707.612M
FY 2010 Q30.69% · $10.806MUnavailable99.31% · $1,552.974MUnavailableUnavailable100% · $1,563.78M
FY 2010 Q43.66% · $23.361M0% · $0M96.34% · $615.538MUnavailable0% · $0M100% · $638.899M
FY 2011 Q11.9% · $14.87M28.18% · $221.105M69.93% · $548.699MUnavailableUnavailable100% · $784.674M
FY 2011 Q22.38% · $26.635M32.86% · $367.503M64.76% · $724.163MUnavailableUnavailable100% · $1,118.301M
FY 2011 Q36.78% · $64.289M0% · $0M93.22% · $883.968MUnavailable0% · $0M100% · $948.257M
FY 2011 Q410.34% · $26.11M0% · $0M89.66% · $226.302MUnavailableUnavailable100% · $252.412M
FY 2012 Q10.21% · $23.199M96.47% · $10,751.636M0.19% · $20.77MUnavailable3.14% · $350M100% · $11,145.605M
FY 2012 Q25.95% · $37.392M0% · $0M38.35% · $241.021MUnavailable55.7% · $350M100% · $628.413M
FY 2012 Q310.71% · $66.584M0% · $0M33% · $205.209MUnavailable56.29% · $350M100% · $621.793M
FY 2012 Q421.47% · $269.871MUnavailable15.91% · $200.041MUnavailable62.62% · $787.139M100% · $1,257.051M
FY 2013 Q14.58% · $38.854M44.67% · $378.645M9.7% · $82.239MUnavailable41.04% · $347.896M100% · $847.634M
FY 2013 Q22.47% · $45.276M0% · $0M0% · $0MUnavailable97.53% · $1,787.641M100% · $1,832.917M
FY 2013 Q316.42% · $37.18M0% · $0M44.18% · $100.02MUnavailable39.4% · $89.187M100% · $226.387M
FY 2013 Q42.59% · $69.472M0% · $0M14.9% · $400.099MUnavailable82.51% · $2,215.167M100% · $2,684.738M
FY 2014 Q126.65% · $163.49M0% · $0M73.35% · $450.087MUnavailableUnavailable100% · $613.577M
FY 2014 Q27.05% · $90.997M0% · $0M92.95% · $1,200MUnavailableUnavailable100% · $1,290.997M
FY 2014 Q35.99% · $135.062M0% · $0M75.35% · $1,700M0% · $0M18.66% · $421M100% · $2,256.062M
FY 2014 Q44.1% · $167.451M0% · $0M48.95% · $2,000.523M0% · $0M46.95% · $1,919M100% · $4,086.974M
FY 2015 Q13.73% · $124MUnavailable90.28% · $3,001M0% · $0M5.99% · $199M100% · $3,324M
FY 2015 Q27.94% · $171MUnavailable41.76% · $900M29.37% · $633M20.93% · $451M100% · $2,155M
FY 2015 Q37.02% · $286MUnavailable74.83% · $3,050M15.38% · $627M2.77% · $113M100% · $4,076M
FY 2015 Q44.08% · $166MUnavailable75.06% · $3,051M15.1% · $614M5.76% · $234M100% · $4,065M
FY 2016 Q11.99% · $177MUnavailable89.99% · $8,000M6.6% · $587M1.42% · $126M100% · $8,890M
FY 2016 Q26.91% · $204MUnavailable33.92% · $1,001M21.21% · $626M37.95% · $1,120M100% · $2,951M
FY 2016 Q310.84% · $198MUnavailable54.76% · $1,000M34.12% · $623M0.27% · $5M100% · $1,826M
FY 2016 Q46.71% · $169MUnavailable39.71% · $1,000M24.58% · $619M28.99% · $730M100% · $2,518M
FY 2017 Q18.43% · $118MUnavailable40.36% · $565M49.07% · $687M2.14% · $30M100% · $1,400M
FY 2017 Q212.77% · $123MUnavailable13.5% · $130M70.61% · $680M3.12% · $30M100% · $963M
FY 2017 Q312.98% · $129MUnavailable15.39% · $153M68.61% · $682M3.02% · $30M100% · $994M
FY 2017 Q4UnavailableUnavailable4.22% · $106M27.18% · $682M68.59% · $1,721M100% · $2,509M
FY 2018 Q13.26% · $212MUnavailable15.97% · $1,039M11.58% · $753M69.19% · $4,500M100% · $6,504M
FY 2018 Q219.97% · $297MUnavailable30.26% · $450M49.76% · $740M0% · $0M100% · $1,487M
FY 2018 Q35.37% · $167MUnavailable14.45% · $449M23.87% · $742M56.31% · $1,750M100% · $3,108M
FY 2018 Q412.74% · $248MUnavailable49.43% · $962M37.82% · $736M0% · $0M100% · $1,946M
FY 2019 Q18.98% · $237MUnavailable31.61% · $834M30.97% · $817M28.43% · $750M100% · $2,638M
FY 2019 Q28.92% · $185MUnavailable28.36% · $588M38.59% · $800M24.12% · $500M100% · $2,073M
FY 2019 Q37.34% · $200MUnavailable8.14% · $222M29.49% · $804M55.03% · $1,500M100% · $2,726M
FY 2019 Q418.3% · $203MUnavailable9.47% · $105M72.23% · $801M0% · $0M100% · $1,109M
FY 2020 Q15.82% · $171M2.15% · $63M45.23% · $1,328M29.77% · $874M17.03% · $500M100% · $2,936M
FY 2020 Q22.47% · $143M81.83% · $4,741M0.93% · $54M14.77% · $856M0% · $0M100% · $5,794M
FY 2020 Q33.68% · $155M23.71% · $1,000M4.77% · $201M20.42% · $861M47.43% · $2,000M100% · $4,217M
FY 2020 Q40.86% · $181M95.05% · $19,938M0% · $0M4.09% · $858M0% · $0M100% · $20,977M
FY 2021 Q14.24% · $165M32.21% · $1,255M7.93% · $309M23.54% · $917M32.08% · $1,250M100% · $3,896M
FY 2021 Q210.37% · $119M8.01% · $92M3.75% · $43M77.87% · $894M0% · $0M100% · $1,148M
FY 2021 Q33.72% · $139M1.44% · $54M3.88% · $145M24.08% · $900M66.88% · $2,500M100% · $3,738M
FY 2021 Q47.43% · $156M0.05% · $1M2.33% · $49M42.57% · $894M47.62% · $1,000M100% · $2,100M
FY 2022 Q111.91% · $247M1.45% · $30M16.97% · $352M45.56% · $945M24.11% · $500M100% · $2,074M
FY 2022 Q26.4% · $143M49.24% · $1,101M3.22% · $72M41.14% · $920M0% · $0M100% · $2,236M
FY 2022 Q35.78% · $157M16.51% · $448M6.63% · $180M34.23% · $929M36.85% · $1,000M100% · $2,714M
FY 2022 Q48.59% · $181M10.35% · $218M37.61% · $792M43.45% · $915M0% · $0M100% · $2,106M
FY 2023 Q15.37% · $109M27.16% · $551M19.71% · $400M47.76% · $969M0% · $0M100% · $2,029M
FY 2023 Q29.42% · $139M16.46% · $243M10.16% · $150M63.96% · $944M0% · $0M100% · $1,476M
FY 2023 Q33.29% · $122M2.13% · $79M8.1% · $300M25.73% · $953M60.75% · $2,250M100% · $3,704M
FY 2023 Q413.55% · $215M17.58% · $279M9.45% · $150M59.42% · $943M0% · $0M100% · $1,587M
FY 2024 Q11.9% · $105M73% · $4,043M7.22% · $400M17.88% · $990M0% · $0M100% · $5,538M
FY 2024 Q24.06% · $130M4.74% · $152M3.12% · $100M30.33% · $972M57.75% · $1,851M100% · $3,205M
FY 2024 Q36.7% · $141M27.07% · $570M14.25% · $300M46.68% · $983M5.32% · $112M100% · $2,106M
FY 2024 Q49.47% · $147M4.83% · $75M22.55% · $350M62.69% · $973M0.45% · $7M100% · $1,552M
FY 2025 Q12.68% · $104M7.04% · $273M18.82% · $730M26.04% · $1,010M45.42% · $1,762M100% · $3,879M
FY 2025 Q26.45% · $107M1.27% · $21M31.79% · $527M59.95% · $994M0.54% · $9M100% · $1,658M
FY 2025 Q38.34% · $147M9.47% · $167M24.67% · $435M57.01% · $1,005M0.51% · $9M100% · $1,763M
FY 2025 Q410.02% · $205M29.77% · $609M11.24% · $230M48.58% · $994M0.39% · $8M100% · $2,046M
FY 2026 Q12.63% · $117M2.45% · $109M9.41% · $419M23.37% · $1,040M62.14% · $2,766M100% · $4,451M
FY 2026 Q21.1% · $140M87.91% · $11,209M2.78% · $355M8.07% · $1,029M0.13% · $17M100% · $12,750M
Jun 30, 2009 through Jun 30, 2026

Operating cash flow

USD millions

$3,573M

Capital expenditures

USD millions

$140M

Free cash flow

USD millions

$3,433M

Stock-based compensation

USD millions

$231M

SBC / free cash flow

% · FCF before SBC deduction

6.73%

SBC / operating cash flow

%

6.47%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$-8.45

Quarterly data

Gilead Sciences cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 20263,5731403,4332316.73%6.47%—$-8.45
FY 2026 Q1Mar 31, 20262,5441172,4272188.98%8.57%—$1.61
FY 2025 Q4Dec 31, 20253,3272053,1222307.37%6.91%——
FY 2025 Q3Sep 30, 20254,1081473,9612305.81%5.6%—$2.43
FY 2025 Q2Jun 30, 202582710772022531.25%27.21%—$1.56
FY 2025 Q1Mar 31, 20251,7571041,65320912.64%11.9%—$1.04
FY 2024 Q4Dec 31, 20242,9751472,8282227.85%7.46%——
FY 2024 Q3Sep 30, 20244,3091414,1682165.18%5.01%—$1
FY 2024 Q2Jun 30, 20241,3251301,19521017.57%15.85%—$1.29
FY 2024 Q1Mar 31, 20242,2191052,1141878.85%8.43%—$-3.34
FY 2023 Q4Dec 31, 20232,1692151,95420110.29%9.27%——
FY 2023 Q3Sep 30, 20231,7551221,63320212.37%11.51%—$1.73
FY 2023 Q2Jun 30, 20232,3381392,1991989%8.47%—$0.83
FY 2023 Q1Mar 31, 20231,7441091,63516510.09%9.46%—$0.8
FY 2022 Q4Dec 31, 20222,5671812,3861747.29%6.78%——
FY 2022 Q3Sep 30, 20222,8631572,7061686.21%5.87%—$1.42
FY 2022 Q2Jun 30, 20221,8021431,6591659.95%9.16%—$0.91
FY 2022 Q1Mar 31, 20221,8402471,5931308.16%7.07%—$0.02
FY 2021 Q4Dec 31, 20213,2051563,0491595.21%4.96%——
FY 2021 Q3Sep 30, 20213,2531393,1141715.49%5.26%—$2.05
FY 2021 Q2Jun 30, 20212,3161192,1971667.56%7.17%—$1.21
FY 2021 Q1Mar 31, 20212,6101652,4451395.69%5.33%—$1.37
FY 2020 Q4Dec 31, 20201,9161811,7351619.28%8.4%—$1.23
FY 2020 Q3Sep 30, 20202,2501552,0951738.26%7.69%—$0.29
FY 2020 Q2Jun 30, 20202,5661432,4231686.93%6.55%—$-2.66
FY 2020 Q1Mar 31, 20201,4361711,26514111.15%9.82%—$1.22
FY 2019 Q4Dec 31, 20192,5802032,3771576.6%6.09%—$2.12
FY 2019 Q3Sep 30, 20192,8992002,6991626%5.59%—$-0.92
FY 2019 Q2Jun 30, 20192,2211852,0361748.55%7.83%—$1.47
FY 2019 Q1Mar 31, 20191,4442371,20714311.85%9.9%—$1.54
FY 2018 Q4Dec 31, 20182,3452482,0971758.35%7.46%—$0
FY 2018 Q3Sep 30, 20182,2121672,0451989.68%8.95%—$1.6
FY 2018 Q2Jun 30, 20181,5732971,27625219.75%16.02%—$1.39
FY 2018 Q1Mar 31, 20182,2702122,05822010.69%9.69%—$1.17
FY 2017 Q4Dec 31, 20172,753——334—12.13%—$-2.96
FY 2017 Q3Sep 30, 20172,6941292,5651134.41%4.19%—$2.06
FY 2017 Q2Jun 30, 20173,5261233,4031023%2.89%—$2.33
FY 2017 Q1Mar 31, 20172,9251182,807893.17%3.04%—$2.05
FY 2016 Q4Dec 31, 20163,4861693,3171023.08%2.93%—$2.34
FY 2016 Q3Sep 30, 20164,3301984,132952.3%2.19%—$2.49
FY 2016 Q2Jun 30, 20164,9402044,736952.01%1.92%—$2.58
FY 2016 Q1Mar 31, 20163,9131773,736882.36%2.25%—$2.53
FY 2015 Q4Dec 31, 20154,8741664,708972.06%1.99%—$3.18
FY 2015 Q3Sep 30, 20154,0962863,810972.55%2.37%—$3.06
FY 2015 Q2Jun 30, 20155,6581715,487961.75%1.7%—$2.92
FY 2015 Q1Mar 31, 20155,7011245,577921.65%1.61%—$2.76
FY 2014 Q4Dec 31, 20143,020.67167.452,853.2295.423.34%3.16%—$2.18
FY 2014 Q3Sep 30, 20144,044.02135.063,908.9699.312.54%2.46%—$1.67
FY 2014 Q2Jun 30, 20144,185.29914,094.383.12.03%1.99%—$2.2
FY 2014 Q1Mar 31, 20141,568.02163.491,404.5382.185.85%5.24%—$1.33
FY 2013 Q4Dec 31, 2013726.7969.47657.3271.6910.91%9.86%—$0.47
FY 2013 Q3Sep 30, 2013753.137.18715.9262.578.74%8.31%—$0.47
FY 2013 Q2Jun 30, 201395345.28907.7355.956.16%5.87%—$0.46
FY 2013 Q1Mar 31, 2013672.138.85633.2561.779.75%9.19%—$0.43
FY 2012 Q4Dec 31, 2012705.73269.87435.8657.1313.11%8.09%—$0.47
FY 2012 Q3Sep 30, 2012745.3766.58678.7854.468.02%7.31%—$0.43
FY 2012 Q2Jun 30, 20121,290.6537.391,253.2648.43.86%3.75%—$0.46
FY 2012 Q1Mar 31, 2012452.9723.2429.7748.7311.34%10.76%—$0.29
FY 2011 Q4Dec 31, 2011978.1126.1195246.64.9%4.76%—$0.44
FY 2011 Q3Sep 30, 2011897.1164.29832.8246.185.55%5.15%—$0.48
FY 2011 Q2Jun 30, 2011943.2626.64916.6250.135.47%5.31%—$0.47
FY 2011 Q1Mar 31, 2011820.5414.87805.6749.476.14%6.03%—$0.4
FY 2010 Q4Dec 31, 2010724.8423.36701.4853.357.61%7.36%—$0.38
FY 2010 Q3Sep 30, 2010739.4210.81728.6251.87.11%7.01%—$0.42
FY 2010 Q2Jun 30, 2010699.0816.05683.0348.057.03%6.87%—$0.4
FY 2010 Q1Mar 31, 2010670.5711.67658.946.847.11%6.99%—$0.46
FY 2009 Q4Dec 31, 2009955.2826.99928.2941.824.51%4.38%—$0.44
FY 2009 Q3Sep 30, 2009860.5318.13842.4148.615.77%5.65%—$0.36
FY 2009 Q2Jun 30, 2009622.9220.87602.0449.218.17%7.9%—$0.31
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · GILD, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.